Investigating the relationship between the pre-existing status of the immune system prior to vaccination and the immune response to Hepatitis B vaccinationWednesday 22 July 2015
High risk populations such as commercial sex workers and fisher folk are being prepared for future HIV vaccine trials.
Final study results provide definitive scientific evidence to support earlier initiation of HIV treatmentTuesday 21 July 2015
Final results from two landmark studies bolstered the scientific case for initiating HIV treatment soon after diagnosis, and an additional study shed new light on the non-daily use of pre-exposure
Stopping cotrimoxazole during antiretroviral therapy raises risk of bacterial illness, malaria, Ugandan trial showsTuesday 12 May 2015
Stopping cotrimoxazole prophylaxis increases the risk of serious bacterial infections and malaria, even at high CD4 cell counts, in people taking antiretroviral therapy in Uganda, results of a rand
Using biometric fingerprinting technology for identification of prospective HIV prevention trial participants enhancing retention in future trials: a community based study in Masaka and KalunguThursday 7 May 2015
After 3 decades of the HIV epidemic, an effective HIV vaccine is still elusive.
Infection and inflammation is a significant risk factor for newborn brain injury (Birth Asphyxia) – ABAaNA StudyThursday 30 April 2015
Scientists at the Medical Research Council/ Uganda Virus Research Institute have released study findings indicating that infection and inflammation is a significant risk factor for new-born brain i
Buganda Kingdom Premier visits Kyamulibwa field stationFriday 2 January 2015
Kyamulibwa MRC/UVRI field station was a hive of activity on Thursday 4th December, 2014 as staff hosted the Premier, Katikiro, of the Buganda Kingdom, Mr. Charles Peter Mayiga.
MRC Mengo clinic and research station openedTuesday 2 December 2014
As part of the events to mark 25 years of existence, the MRC/UVRI Uganda Research Unit on AIDS opened their forth field station on 7th November, 2014.